Cellectis S.A. (CLLS)
NASDAQ: CLLS · Real-Time Price · USD
4.370
+0.260 (6.33%)
At close: Jan 22, 2026, 4:00 PM EST
4.370
0.00 (0.00%)
After-hours: Jan 22, 2026, 4:00 PM EST
Cellectis Market Cap
Cellectis has a market cap or net worth of $310.17 million as of January 22, 2026. Its market cap has increased by 156.76% in one year.
Market Cap
310.17M
Enterprise Value
346.83M
1-Year Change
156.76%
Ranking
Category
Stock Price
$4.37
Market Cap Chart
Since March 25, 2015, Cellectis's market cap has decreased from $1.34B to $310.17M, a decrease of -76.92%. That is a compound annual growth rate of -12.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 297.30M | -15.08% |
| Dec 31, 2025 | 350.10M | 169.72% |
| Dec 31, 2024 | 129.80M | -24.18% |
| Dec 29, 2023 | 171.20M | 78.89% |
| Dec 30, 2022 | 95.70M | -74.09% |
| Dec 31, 2021 | 369.30M | -67.88% |
| Dec 31, 2020 | 1.15B | 58.27% |
| Dec 31, 2019 | 726.40M | 2.87% |
| Dec 31, 2018 | 706.10M | -31.45% |
| Dec 29, 2017 | 1.03B | 72.73% |
| Dec 30, 2016 | 596.30M | -43.80% |
| Dec 31, 2015 | 1.06B | -21.04% |
| Mar 25, 2015 | 1.34B | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 289.32B |
| Novartis AG | 278.23B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 261.50B |